Very pleased to share our recently published paper on RSV-associated admissions in children in 7 European countries. A lot of effort from a lot of people to get access to this data and put it all together! And more results to come soon 🤞
https://t.co/hUuYE1GIGc
See our latest work on global disease burden estimates of #RSV in @TheLancet. Important implications for RSV immunisation strategy for infants. Thanks to all collaborators who contribute valuable RSV epidemiology data to this work!👏👏👏
Joining virtual #ICPE20? IQVIA’s #RWE experts are contributing to a range of events at ICPE All Access from September 16–17. Discover our thought leadership activities: https://t.co/5sp2vx7liR
Estimating Transmission Parameters for Respiratory Syncytial - our latest evidence synthesis on the transmission dynamics of RSV, including estimation of year-to-year gains and losses of immunity https://t.co/1xzJwuNAFi
I think it's probably not right to claim the NHS "coped with the first wave of covid".
Yes, we avoided a triage situation of choosing between covid patients for the last ICU bed.
But that was bought at the cost of stopping everything else. That's not coping, it's redistributing.
Today, three of the authors have retracted "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" Read the Retraction notice and statement from The Lancet https://t.co/pPNCJ3nO8n
recruitment started today in Edinburgh for Phase II/III of the COVID-19 Oxford Vaccine
impressive team effort! with over 250 clinical staff, mainly volunteers, aiming to screen 1000 participants in Lothian
@NHS_Lothian@EdinburghUni@emerge_research
https://t.co/X8IMS1yBUP
Letting the virus go without measures to track & suppress it is back to Russian Roulette: maybe you’ll be exposed, maybe you won’t. Maybe you’ll have mild symptoms, maybe you won’t. Maybe you’ll have long-term health problems from the virus, maybe you won’t.
In case you haven't already seen it our #COVID19 vaccine tracker shows the progress of vaccines in the development pipeline around the world. Regularly updated by the creator Dr Ed Parker from @LSHTM_Vaccines https://t.co/88wPqLzfsy
Would anyone be able to share any studies/resources on adherence to COVID-19 government response measures (eg. social distancing)? I’m v keen to read more about this - and interested in any country-specific examples (anywhere in the world) as well as general commentaries!
Help slow the spread of #COVID19 and identify at risk cases sooner by self-reporting your symptoms daily, even if you feel well 🙏🏼. Download the app https://t.co/paR24RKCAZ